Terns Pharmaceuticals Ownership | Who Owns Terns Pharmaceuticals?
Terns Pharmaceuticals Ownership Summary
Terns Pharmaceuticals is owned by 105.30% institutional investors, 0.26% insiders. Soleus capital management is the largest institutional shareholder, holding 10.46% of TERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.44% of its assets in Terns Pharmaceuticals shares.
TERN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Terns Pharmaceuticals | 105.30% | 0.26% | -5.56% |
Sector | Healthcare Stocks | 56.95% | 9.26% | 33.79% |
Industry | Biotech Stocks | 68.60% | 8.88% | 22.52% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Soleus capital management | 8.14M | 10.46% | $45.11M |
Orbimed advisors | 7.56M | 9.72% | $41.90M |
Vivo capital | 6.90M | 8.86% | $38.20M |
Blackrock funding, inc. /de | 5.74M | 7.38% | $31.82M |
Deep track capital, lp | 5.58M | 7.17% | $30.89B |
Schonfeld strategic advisors | 4.75M | 6.11% | $26.32M |
Blackrock | 4.12M | 5.53% | $28.06M |
Vanguard group | 3.87M | 4.97% | $21.44M |
Nuveen asset management | 2.63M | 3.38% | $14.59M |
Candriam s.c.a. | 2.15M | 2.77% | $11.93M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Superstring capital management lp | 2.02M | 9.69% | $11.19M |
Vivo capital | 6.90M | 4.28% | $38.20M |
Soleus capital management | 8.14M | 2.83% | $45.11M |
Acuta capital partners | 447.50K | 2.49% | $2.48B |
Timessquare capital management | 621.64K | 1.45% | $92.18M |
Robeco schweiz | 411.27K | 1.17% | $60.99M |
Deep track capital, lp | 5.58M | 1.15% | $30.89B |
Orbimed advisors | 7.56M | 0.86% | $41.90M |
Altium capital management lp | 475.00K | 0.75% | $2.63M |
Parkman healthcare partners | 829.11K | 0.61% | $4.59M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Candriam s.c.a. | 2.15M | 0.07% | 2.15M |
Soleus capital management | 8.14M | 2.83% | 1.92M |
Schonfeld strategic advisors | 4.75M | 0.15% | 1.46M |
Blackrock funding, inc. /de | 5.74M | 0.00% | 1.04M |
Norges bank | 849.39K | 0.00% | 849.39K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vr adviser | 1.08M | 0.41% | -2.33M |
Avidity partners management lp | - | - | -2.13M |
Janus henderson group | - | - | -2.00M |
Exoduspoint capital management, lp | 10.82K | 0.00% | -1.64M |
Point72 asset management | 1.25M | 0.02% | -1.46M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Candriam s.c.a. | 2.15M | 0.07% | 2.15M | $11.93M |
Norges bank | 849.39K | 0.00% | 849.39K | $4.71M |
Bnp paribas arbitrage, snc | 224.26K | 0.00% | 224.26K | $1.24M |
Hightower advisors | 84.43K | 0.00% | 84.43K | $467.74K |
Crestline management, lp | 66.60K | 0.01% | 66.60K | $368.96K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -9.00 |
Pnc financial services group | -17.00 |
Capital performance advisors llp | -23.00 |
Lindbrook capital | -63.00 |
Allworth financial lp | -90.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 149 | -9.70% | 81,944,156 | 3.09% | 105 | 1.01% | 94 | -8.74% | 31 | -18.42% |
Sep 30, 2024 | 165 | 17.86% | 79,491,270 | 19.38% | 102 | 1.28% | 103 | 8.42% | 38 | 65.22% |
Jun 30, 2024 | 140 | 19.66% | 66,584,833 | 5.52% | 89 | 1.24% | 95 | 48.44% | 23 | -28.13% |
Mar 31, 2024 | 117 | 6.36% | 63,102,304 | -0.76% | 84 | 1.10% | 64 | 4.92% | 32 | 39.13% |
Dec 31, 2023 | 110 | 12.24% | 63,584,999 | 3.76% | 87 | 1.20% | 61 | 48.78% | 23 | -36.11% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.07M | 2.44% | - |
iShares Russell 2000 ETF | 1.88M | 2.21% | -14.25K |
CREF Stock R1 | 1.42M | 1.67% | - |
Belfius Equities Cure C Cap | 1.29M | 1.51% | - |
Fidelity Select Biotechnology | 1.09M | 1.29% | 1.09M |
US Small-Cap Growth II Equity Comp | 1.04M | 1.23% | 529.45K |
T. Rowe Price New Horizons | 1.04M | 1.23% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 936.74K | 1.10% | 254.79K |
Fidelity Small Cap Growth | 877.41K | 1.04% | -1.09M |
Candriam Eqs L Biotech C USD Cap | 868.73K | 1.02% | 868.73K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 30, 2024 | Jung Melita Sun | Chief Business Officer | Buy | $11.50K |
Nov 30, 2024 | Burroughs Amy L. | Chief Executive Officer | Buy | $2.61K |
Jan 02, 2025 | Kuriakose Emil | Chief Medical Officer | Sell | $25.61K |
Jan 06, 2025 | Vignola Mark J. | Chief Financial Officer | Sell | $52.50K |
Jan 02, 2025 | Vignola Mark J. | Chief Financial Officer | Sell | $46.52K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 5 |
2024 Q4 | 1 | - |
2024 Q3 | 2 | 18 |
2024 Q2 | 2 | 9 |
2024 Q1 | - | - |
TERN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools